(a) whether there is duplication of trade names of pharmaceutical companies in the country;
(b) if so, whether any policy has been formulated by the Government to check such activities;and
(c) if so, the details there?
(a) whether there is duplication of trade names of pharmaceutical companies in the country;
(b) if so, whether any policy has been formulated by the Government to check such activities;and
(c) if so, the details there?
MINISTER OF THE STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS (SHRI SRIKANT KUMAR JENA)
(a): No such information has come to the notice of the Department of Pharmaceuticals.
(b)and(c): Section 20(2) of the Companies Act, 1956 provides against duplication of a name
(including a trade name) which is identical with or too nearly resembles the name by which
a company in existence has been previously registered or a registered trademark or pending
trademark application under the Trade Marks Act, 1999.